Bi Asset Management Fondsmaeglerselskab A Merck & Co., Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

$6.11 Billion
Q2 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 313,563 shares of MRK stock, worth $31.9 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

313,563

Previous 293,621 6.79%

Holding current value

$31.9 Million

Previous $38.7 Million 0.2%

% of portfolio

0.64%

Previous 0.73%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $2.47 Million - $2.65 Million	19,942 Added 6.79%	313,563 $38.8 Million
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $2.82 Million - $3.29 Million	24,930 Added 9.28%	293,621 $38.7 Million
Q4 2023 Feb 09, 2024	SELL	$100.18 - $109.02 $6.38 Million - $6.94 Million	-63,636 Reduced 19.15%	268,691 $29.3 Million
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $41.9 Million - $46.6 Million	-407,453 Reduced 55.08%	332,327 $34.2 Million
Q2 2023 Aug 03, 2023	BUY	$108.61 - $118.38 $12.1 Million - $13.2 Million	111,449 Added 17.74%	739,780 $85.4 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $12.4 Million - $13.9 Million	-120,740 Reduced 16.12%	628,331 $66.8 Million
Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $29 Million - $37.1 Million	331,196 Added 79.26%	749,071 $83.1 Million
Q3 2022 Nov 07, 2022	BUY	$84.53 - $94.96 $2.03 Million - $2.28 Million	24,045 Added 6.11%	417,875 $36 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $35,483 - $40,222	-425 Reduced 0.11%	393,830 $35.9 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $3.51 Million - $3.93 Million	-47,745 Reduced 10.8%	394,255 $32.3 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $779,973 - $977,017	10,791 Added 2.5%	442,000 $33.9 Million
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $1.76 Million - $1.94 Million	-24,562 Reduced 5.39%	431,209 $32.4 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $84,231 - $93,168	1,198 Added 0.26%	455,771 $35.4 Million
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $7.68 Million - $9.05 Million	-111,586 Reduced 19.71%	454,573 $35 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $4.45 Million - $4.93 Million	61,947 Added 12.29%	566,159 $46.3 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $2.2 Million - $2.5 Million	30,122 Added 6.35%	504,212 $41.8 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $3.51 Million - $4 Million	49,905 Added 11.76%	474,090 $36.7 Million
Q1 2020 May 11, 2020	BUY	$63.36 - $87.82 $2.2 Million - $3.05 Million	34,771 Added 8.93%	424,185 $32.6 Million
Q4 2019 Mar 19, 2020	SELL	$77.58 - $87.54 $2.52 Million - $2.84 Million	-32,471 Reduced 7.7%	389,414 $35.4 Million
Q3 2019 Mar 19, 2020	BUY	$76.08 - $82.93 $1.56 Million - $1.7 Million	20,500 Added 5.11%	421,885 $35.5 Million
Q2 2019 Mar 19, 2020	BUY	$69.84 - $81.59 $916,580 - $1.07 Million	13,124 Added 3.38%	401,385 $33.7 Million
Q1 2019 Mar 19, 2020	BUY	$69.58 - $79.36 $5.72 Million - $6.52 Million	82,161 Added 26.84%	388,261 $32.3 Million
Q4 2018 Mar 19, 2020	BUY	$65.24 - $75.71 $20 Million - $23.2 Million	306,100 New	306,100 $23.4 Million
Q2 2015 Mar 19, 2020	SELL	N/A	-234,700 Closed	0 $0
Q1 2015 Mar 19, 2020	SELL	N/A	-5,600 Reduced 2.33%	234,700 $13.5 Million
Q4 2014 Mar 19, 2020	SELL	N/A	-25,800 Reduced 9.7%	240,300 $13.6 Million
Q3 2014 Mar 19, 2020	BUY	N/A	5,200 Added 1.99%	266,100 $15.8 Million
Q2 2014 Mar 19, 2020	SELL	N/A	-21,400 Reduced 7.58%	260,900 $15.1 Million
Q1 2014 Mar 19, 2020	BUY	N/A	282,300	282,300 $16 Million

Others Institutions Holding MRK

# of Institutions

3,805

Shares Held

1.92B

Call Options Held

13.4M

Put Options Held

10.6M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $258B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Merck & Co., Inc. Transaction History